Over 20 years of BD and MA experience in pharmaceutical, diagnostic and medical devices companies in both the US and China. He has led many cross-border deals by creatively bridging differences among different parties. Used to be a scientist with Bayer Corporation, BD of Eli Lilly in the US, and CFO at Shanghai Sunway Biotech Frequent speaker in various investment conferences. MS, MBA from Northwestern University (Kellogg)
Previously worked in healthcare investment at Morningside Ventures for 8 years and led over a dozen transactions and portfolio management. In the US, she used to work as a healthcare investment banker with RBC Capital Markets, she also held positions in biotech management (QIAGEN) and public accounting (PWC). Ph.D. in Biochemistry from the University of South Florida, and MBA from Cornell University.
Was in charge of marketing efforts of imported product lines at Runda Medical for five years, covering multiple fields, including biochemistry, immunology, blood typing, and glycated hemoglobin. Conducted research in the department of pharmacology at University of Illinois at Chicago. Bachelor degree from Shanghai Jiaotong University and a MS in biological sciences from the Illinois Institute of Technology.
10 years experience in VC and portfolio companies. Worked at top VC firms in both U.S and China , including Morningside ventures, Burrill venture and AIListCapital Managing partner at WEBridge Ventures Expertise in digital health and MedTech Financial and MA experience with one successful exit Medical doctor, specialty in Diabetes; MBA from University of Southern California (USC)
At BFC Group, he has been involved in multiple cross-border BD and financing projects in healthcare industry, including Eutilex, Resverlogix, OMNI, Asieris, YZY. Prior to BFC, he worked in Sanofi and Boehriunger Ingelheim for 8 years in Marketing and Sales division. Bachelor and Masters degree from China Pharmaceutical University and MBA from Chang Cheung Graduate Business School (CKGSB).
Over nine years of experience in bio-pharmaceuticals area in both drug discovery and business development. Familiar the drug discovery process from medicinal chemistry to PD, DMPK, GLO-TOX and CMC. Prior to BFC, he worked in WuXi AppTec, Asychem and Simcere around 8 years in RD and BD department. Licensed pharmacist Master and B.Sc. from Huazhong University of Science and Technology.
At BFC Group, she has been leading multiple financing in respiratory and oncology area, including KBP, OMNI and ImmuneOnco. Before BFC, she worked in Drug Purchasing and Supplier Management division at Shanghai Pharma, a public-listed company listed in Hong Kong. Registered pharmacist Master and B. Sc. from China Pharmaceutical University.
Priorto BFC, she had rich experience in professional services for HK/US/CHINA listedcompanies at PWC, including annual auditing, IPO and senior notes issuance. Shealso engaged in market entry projects in AstraZeneca and cross-border MAtransactions in Sinolink Securities. AICPACertificate holder Bachelor degree fromOhio State University, and MBA from China Europe International Business School (CEIBS)
Master, MBA. Director in Prosperico Venture for 4 years, responsible for investment in healthcare sector. Over 8 years of experience in sales/marketing in biotech sector. B.S. degree from Fudan University, and MBA degree from Cheung Kong Graduate School of Business.
At BFC Group, she has been leading multiple cross-border BD and MA transactions, in healthcare industry including Genext, Eutilex, Cascadian and InnoMed. Prior to BFC, she worked as an analyst at Lapam Capital, a healthcare-focused private equity fund. B.Sc. from Haas School of Business at University of California, Berkeley.
More than six-year experience in sales, marketing and strategic planning in medical imaging field. Before BFC, he has worked in Roche Diagnosis, managing the internal operation project instrument life-cycle process. Bachelor degree from Sun Yat-Sen University medical school and IMBA degree from Shanghai JiaoTong University, and exchange program in SDA Bocconi, Italy.
MBA,CiCPA. Rich working experience in strategy and business analysis in pharmaceutical company. Engaged in pharmaceutical equity research in Sinolink Securities and venture investment in Sinopharm Capital. Bachelor degree from Renmin University of China and MBA from Shanghai Advanced Institute of Finance (SAIF).
Six years of technology experience for Medical device, including the RD and manufacturing roles. Familiar with the whole process from idea design to mass production, used to work in MicroPort and Medtronic. Two years of consulting experience in China Healthcare Consultant (Group) Company Limited, conducted the industry research and supported the branded forum B.E. of Nanjing Forestry University and M.S. of Tongji University.
Worked as an analyst intern at Guangfa Xinde Securities with a focus on medical device investment deal in Israel. Worked as an intern at HY Capital. He mainly conducted healthcare equity research. Worked as resident at Shanghai First People's Hospital MD from Fudan University. Trained as orthopedic surgeon.
Graduated from Central South University. Prior to BFC, she worked at Abbott.